Abnormal chemokine receptor profile on circulating T lymphocytes from nonallergic asthma patients

International Archives of Allergy and Immunology

Volumn 164, Issue 3, 2014, Pages 228-236

  Barbarroja Escudero, José ^a,b   Prieto Martin, Alfredo ^a   Monserrat Sanz, Jorge ^a   Reyes Martin, Eduardo ^a   Diaz Martin, David ^a   Antolin Amerigo, Dario ^a,b   Rodriguez Rodriguez, Mercedes ^a,b   Canseco Gonzalez, Felipe ^a   Kremer, Leonor ^c,d   Martinez A, Carlos ^a,d   Alvarez Mon, Melchor ^a,b  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b Allergy Division   (Spain)

^c Protein Tools Unit   (Spain)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Chemokine receptor; Nonallergic asthma; T lymphocyte

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CD8 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; FLUTICASONE PROPIONATE; MONOCLONAL ANTIBODY; SALBUTAMOL; TERBUTALINE; ANDROSTANE DERIVATIVE; CCR5 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN; CD3 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CXCR3 PROTEIN, HUMAN; FLUTICASONE; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ARTICLE; ASTHMA; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; NONALLERGIC ASTHMA; OBSTRUCTIVE AIRWAY DISEASE; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; CROSS-SECTIONAL STUDY; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE COUNT; MIDDLE AGED; SKIN TEST;

ANDROSTADIENES; ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, CD8; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CCR6; RECEPTORS, CXCR3; SKIN TESTS; T-LYMPHOCYTES;

EID: 84906619181     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000365627     Document Type: Article

References (28)

1. Kallinich T, Schmidt S, Hamelman E, Fischer A, Qin S, Luttmann W, Virchow JC, Kroczek RA: Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy 2005; 35: 26-33.
2. Pease JE, Williams TJ: Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 2006; 118: 305-318.
3. Smit JJ, Lukacs NW: A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol 2006; 533: 277-288.
4. Garcia G, Humbert M, Capel F, Rimanio AC, Escourrou P, Emilie D, Godot V: Chemokine receptor expression on allergen-specific T cells in asthma and allergic bronchopulmonary aspergillosis. Allergy 2007; 62: 170-177.
5. Francis JN, Sabroe I, Lloyd CM, Durham SR, Till SJ: Elevated CCR6+ CD4+ T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response. Clin Exp Immunol 2008; 152: 440-447.
6. Liang R, Wang L, Wang G: New insight into genes in association with asthma: literaturebased mining and network centrality analysis. Chin Med J (Engl) 2013; 126: 2472-2479.
7. Mendez-Enriquez E, Medina-Tamayo J, Soldevila G, Fortoul TI, Anton B, Flores-Romo L, Garcia-Zepeda EA: A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: implications as a potential therapeutic treatment of asthma. Int Immunopharmacol 2014; 20: 1-11.
8. Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, Frosali F, Querci V, Angeli R, Matucci A, Fambrini M, Liotta F, Parronchi P, Maggi E, Romagnani S, Annunziato F: Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125: 222-230.
9. Hiraguchi Y, Tanida H, Sugimoto M, Hosoki K, Nagao M, Tokuda R, Fujisawa T: 1,25-dihydroxyvitamin D 3 upregulates functional Cx-C chemokine receptor type 4 expression in human eosinophils. Int Arch Allergy Immunol 2012; 158: 51-57.
10. Mikhak Z, Fukui M, Farsidjani A, Medoff BD, Tager AM, Luster AD: Contribution of CCR4 and CCR8 to antigen-specific TH2 cell trafficking in allergic pulmonary inflammation. J Allergy Clin Immunol 2009; 123: 67-73.
11. Shin YS, Takeda K, Ohnishi H, Jia Y, Shiraishi Y, Cox ML, Fine JS, Rosenblum S, Lundel D, Jenh CH, Manfra DJ, Gelfand EW: Targeting CXCR3 reduces ligand-induced T-cell activation but not development of lung allergic responses. Ann Allergy Asthma Immunol 2011; 107: 145-153.
12. Lin Y, Yan H, Xiao Y, Piao H, Xiang R, Jiang L, Chen H, Huang K, Guo Z, Zhou W, Lu B, Gao J: Attenuation of antigen-induced airway hyperresponsiveness and inflammation in CXCR3 knockout mice. Respir Res 2011; 12: 123.
13. Glatzer F, Mommert S, Kother B, Gschwandtner M, Stark H, Werfel T, Gutzmer R: Histamine downregulates the Th1-associated chemokine IP-10 in monocytes and myeloid dendritic cells. Int Arch Allergy Immunol 2014; 163: 11-19.
14. Prieto A, Diaz D, Barcenilla H, Castrillo C, Monserrat J, Merino AG, Alvarez-Mon M; GENIO II-group: Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis. J Clin Immunol 2006; 26: 101-112.
15. Robak E, Sysa-Jdrzejowska A, Robak T, Smolewski P: Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol 2006; 25: 225-233.
16. Inukai Y, Momobayashi A, Sugawara N, Aso Y: Changes in expression of T-helper (Th) 1-and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferoninducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves disease. Eur J Endocrinol 2007; 156: 623-630.
17. Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institutes of Health Publication 02-3659. Bethesda, National Institutes of Health, National Heart, Lung, and Blood Institute, 2006. http://www.ginasthma.org (accessed December 19, 2007).
18. Adams NP, Bestall JC, Jones PW, Lasserson TJ, Griffiths B, Cates C: Inhaled fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev 2005; 20:CD003534.
19. Boyum A: Separation of leukocytes from blood and bone marrow -introduction. Scand J Clin Lab Invest Suppl 1968; 97: 7.
20. Monserrat J, Sanchez MA, de Paz R, Diaz D, Mur S, Reyes E, Prieto A, de la Hera A, Martinez-A C, Alvarez-Mon M: Distinctive patterns of naive/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients. Cytometry B Clin Cytom 2014; 86: 32-43.
21. Carramolino L, Kremer L, Goya I, Varona R, Buesa JM, Gutierrez J, Zaballos A, Martinez-A C, Marquez G: Down-regulation of the beta-chemokine receptor CCR6 in dendritic cells mediated by TNF-alpha and IL-4. J Leukoc Biol 1999; 66: 837-844.
22. Garcia-Lopez MA, Sanchez-Madrid F, Rodriguez-Frade JM, Mellado M, Acevedo A, Garcia MI, Albar JP, Martinez C, Marazuela M: CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab Invest 2001; 81: 409-418.
23. Abdulamir AS, Hafidh RR, Abubakar F, Abbas KA: Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma. BMC Immunol 2008; 9: 73.
24. Thomas SY, Banerji A, Medoff BD, Lilly CM, Luster AD: Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway. J Immunol 2007; 179: 1901-1912.
25. Kurashima K, Fujimura M, Myou S, Kasahara K, Tachibana H, Amemiya N, Ishiura Y, Onai N, Matsushima K, Nakao S: Effects of oral steroids on blood CXCR3+ and CCR4+ T cells in patients with bronchial asthma. Am J Respir Crit Care Med 2001; 164: 754-758.
26. Matsukura S, Kurokawa M, Homma T, Watanabe S, Suzuki S, Ieki K, Takeuchi H, Notomi K, Schleimer RP, Kawaguchi M, Kokubu F: Basic research on virus-induced asthma exacerbation: inhibition of inflammatory chemokine expression by fluticasone propionate. Int Arch Allergy Immunol 2013; 161: 84-92.
27. Brinkmann V, Kristofic C: Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO-and CD45RO+ subsets. J Immunol 1995; 155: 3322-3328.
28. Oehling AG, Akdis CA, Schapowal A, Blaser K, Schmitz M, Simon HU: Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 1997; 52: 122-123.